
What We're Reading: US Flu Season Worsening; 1 Dose of HPV Vaccine Exhibits Efficacy; Generic Makers to Appeal Pay-to-Delay Ruling
The current US flu season is shaping up to be among the worst in decades; a single dose of the HPV vaccine shows efficacy in an analysis; generic manufacturers plan to appeal a California ruling on pay-to-delay deals.
One of the Worst US Flu Seasons in Decades
As reported by
Single Dose of HPV Vaccine May Provide Protection
An analysis published in
Generic Manufacturers to Appeal California Ruling on Pay-to-Delay Deals
After a federal judge declined to block a new California law that bans the so-called “pay-to-delay” deals between drug makers, a trade group within the pharmaceutical industry plans to pursue an appeal in a higher court, according to
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.